Loading…
Neuroprotective activity of stiripentol with a possible involvement of voltage-dependent calcium and sodium channels
A growing body of data has shown that recurrent epileptic seizures may be caused by an excessive release of the excitatory neurotransmitter glutamate in the brain. Glutamatergic overstimulation results in massive neuronal influxes of calcium and sodium through N‐methyl‐D‐aspartate (NMDA), α‐amino‐3‐...
Saved in:
Published in: | Journal of neuroscience research 2016-02, Vol.94 (2), p.179-189 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4948-ca1df7e6b72df4739a25ba59631f6214911be41a71414bb8142312fab0942d7e3 |
---|---|
cites | cdi_FETCH-LOGICAL-c4948-ca1df7e6b72df4739a25ba59631f6214911be41a71414bb8142312fab0942d7e3 |
container_end_page | 189 |
container_issue | 2 |
container_start_page | 179 |
container_title | Journal of neuroscience research |
container_volume | 94 |
creator | Verleye, Marc Buttigieg, Dorothée Steinschneider, Rémy |
description | A growing body of data has shown that recurrent epileptic seizures may be caused by an excessive release of the excitatory neurotransmitter glutamate in the brain. Glutamatergic overstimulation results in massive neuronal influxes of calcium and sodium through N‐methyl‐D‐aspartate (NMDA), α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid, and kainic acid glutamate subtype receptors and also through voltage‐gated calcium and sodium channels. These persistent and abnormal sodium and calcium entry points have deleterious consequences (neurotoxicity) for neuronal function. The therapeutic value of an antiepileptic drug would include not only control of seizure activity but also protection of neuronal tissue. The present study examines the in vitro neuroprotective effects of stiripentol, an antiepileptic compound with γ‐aminobutyric acidergic properties, on neuronal–astroglial cultures from rat cerebral cortex exposed to oxygen–glucose deprivation (OGD) or to glutamate (40 µM for 20 min), two in vitro models of brain injury. In addition, the affinity of stiripentol for the different glutamate receptor subtypes and the interaction with the cell influx of Na+ and of Ca2+ enhanced by veratridine and NMDA, respectively, are assessed. Stiripentol (10–100 µM) included in the culture medium during OGD or with glutamate significantly increased the number of surviving neurons relative to controls. Stiripentol displayed no binding affinity for different subtypes of glutamate receptors (IC50 > 100 µM) but significantly blocked the entry of Na+ and Ca2+ activated by veratridine and NMDA, respectively. These results suggest that Na+ and Ca2+ channels could contribute to the neuroprotective properties of sitiripentol. © 2015 Wiley Periodicals, Inc.
Stiripentol protected neurons and astrocytes against seizure‐induced injuries by modulating the function of calcium and sodium channels. This property illustrated in the figure could be combined with its antiepileptic activity, which is mediated mainly by the GABA system. |
doi_str_mv | 10.1002/jnr.23688 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1780516910</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3895687641</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4948-ca1df7e6b72df4739a25ba59631f6214911be41a71414bb8142312fab0942d7e3</originalsourceid><addsrcrecordid>eNp1kU9v1DAQxS1ERZfCgS-AInGBQ1qP7djxkS60tKqWCoF6tJxkQr3kz2I7W_bb47BtD5U4zYz9myf7PULeAD0GStnJevDHjMuyfEYWQLXKRSHUc7KgXNJcUGCH5GUIa0qp1gV_QQ6ZLAAELxckrnDy48aPEevotpjZubi4y8Y2C9F5t8Ehjl125-JtZrPNGIKrOszcsB27LfbpdkbTEO1PzBtMfDMf1rar3dRndmiyMDZzW9_aYcAuvCIHre0Cvr6vR-TH2efvyy_51dfzi-XHq7wWWpR5baFpFcpKsaYVimvLisoWWnJoJQOhASoUYBUIEFVVgmAcWGsrqgVrFPIj8n6vm_73e8IQTe9CjV1nBxynYECVtACpgSb03RN0PU5-SK9LlNBUAmNloj7sqdonHzy2ZuNdb_3OADVzFCZFYf5Fkdi394pT1WPzSD54n4CTPXDnOtz9X8lcrr49SOb7DRci_nncsP6XkYqrwtyszs1SipvT60_X5oz_BQ3go1A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1749061228</pqid></control><display><type>article</type><title>Neuroprotective activity of stiripentol with a possible involvement of voltage-dependent calcium and sodium channels</title><source>Wiley</source><creator>Verleye, Marc ; Buttigieg, Dorothée ; Steinschneider, Rémy</creator><creatorcontrib>Verleye, Marc ; Buttigieg, Dorothée ; Steinschneider, Rémy</creatorcontrib><description>A growing body of data has shown that recurrent epileptic seizures may be caused by an excessive release of the excitatory neurotransmitter glutamate in the brain. Glutamatergic overstimulation results in massive neuronal influxes of calcium and sodium through N‐methyl‐D‐aspartate (NMDA), α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid, and kainic acid glutamate subtype receptors and also through voltage‐gated calcium and sodium channels. These persistent and abnormal sodium and calcium entry points have deleterious consequences (neurotoxicity) for neuronal function. The therapeutic value of an antiepileptic drug would include not only control of seizure activity but also protection of neuronal tissue. The present study examines the in vitro neuroprotective effects of stiripentol, an antiepileptic compound with γ‐aminobutyric acidergic properties, on neuronal–astroglial cultures from rat cerebral cortex exposed to oxygen–glucose deprivation (OGD) or to glutamate (40 µM for 20 min), two in vitro models of brain injury. In addition, the affinity of stiripentol for the different glutamate receptor subtypes and the interaction with the cell influx of Na+ and of Ca2+ enhanced by veratridine and NMDA, respectively, are assessed. Stiripentol (10–100 µM) included in the culture medium during OGD or with glutamate significantly increased the number of surviving neurons relative to controls. Stiripentol displayed no binding affinity for different subtypes of glutamate receptors (IC50 > 100 µM) but significantly blocked the entry of Na+ and Ca2+ activated by veratridine and NMDA, respectively. These results suggest that Na+ and Ca2+ channels could contribute to the neuroprotective properties of sitiripentol. © 2015 Wiley Periodicals, Inc.
Stiripentol protected neurons and astrocytes against seizure‐induced injuries by modulating the function of calcium and sodium channels. This property illustrated in the figure could be combined with its antiepileptic activity, which is mediated mainly by the GABA system.</description><identifier>ISSN: 0360-4012</identifier><identifier>EISSN: 1097-4547</identifier><identifier>DOI: 10.1002/jnr.23688</identifier><identifier>PMID: 26511438</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid - pharmacokinetics ; Animals ; Brain-Derived Neurotrophic Factor - pharmacology ; Calcium - metabolism ; Cells, Cultured ; Cerebral Cortex - cytology ; Dioxolanes - pharmacology ; Embryo, Mammalian ; Fibrinolytic Agents - pharmacokinetics ; Glucose - deficiency ; Glutamic Acid - pharmacology ; Hippocampus - cytology ; Hirudins - pharmacokinetics ; L-glutamate ; Mice, Inbred C57BL ; Neurofilament Proteins - metabolism ; Neuroglia - drug effects ; neuronal-astroglial culture ; Neurons - drug effects ; neuroprotection ; Neuroprotective Agents - pharmacology ; oxygen-glucose deprivation ; Protein Binding - drug effects ; Rats ; Receptors, Glutamate - metabolism ; Recombinant Proteins - pharmacokinetics ; Sodium - metabolism ; stiripentol ; Tritium - pharmacokinetics ; voltage-gated sodium and calcium channels</subject><ispartof>Journal of neuroscience research, 2016-02, Vol.94 (2), p.179-189</ispartof><rights>2015 Wiley Periodicals, Inc.</rights><rights>2016 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4948-ca1df7e6b72df4739a25ba59631f6214911be41a71414bb8142312fab0942d7e3</citedby><cites>FETCH-LOGICAL-c4948-ca1df7e6b72df4739a25ba59631f6214911be41a71414bb8142312fab0942d7e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26511438$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Verleye, Marc</creatorcontrib><creatorcontrib>Buttigieg, Dorothée</creatorcontrib><creatorcontrib>Steinschneider, Rémy</creatorcontrib><title>Neuroprotective activity of stiripentol with a possible involvement of voltage-dependent calcium and sodium channels</title><title>Journal of neuroscience research</title><addtitle>Journal of Neuroscience Research</addtitle><description>A growing body of data has shown that recurrent epileptic seizures may be caused by an excessive release of the excitatory neurotransmitter glutamate in the brain. Glutamatergic overstimulation results in massive neuronal influxes of calcium and sodium through N‐methyl‐D‐aspartate (NMDA), α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid, and kainic acid glutamate subtype receptors and also through voltage‐gated calcium and sodium channels. These persistent and abnormal sodium and calcium entry points have deleterious consequences (neurotoxicity) for neuronal function. The therapeutic value of an antiepileptic drug would include not only control of seizure activity but also protection of neuronal tissue. The present study examines the in vitro neuroprotective effects of stiripentol, an antiepileptic compound with γ‐aminobutyric acidergic properties, on neuronal–astroglial cultures from rat cerebral cortex exposed to oxygen–glucose deprivation (OGD) or to glutamate (40 µM for 20 min), two in vitro models of brain injury. In addition, the affinity of stiripentol for the different glutamate receptor subtypes and the interaction with the cell influx of Na+ and of Ca2+ enhanced by veratridine and NMDA, respectively, are assessed. Stiripentol (10–100 µM) included in the culture medium during OGD or with glutamate significantly increased the number of surviving neurons relative to controls. Stiripentol displayed no binding affinity for different subtypes of glutamate receptors (IC50 > 100 µM) but significantly blocked the entry of Na+ and Ca2+ activated by veratridine and NMDA, respectively. These results suggest that Na+ and Ca2+ channels could contribute to the neuroprotective properties of sitiripentol. © 2015 Wiley Periodicals, Inc.
Stiripentol protected neurons and astrocytes against seizure‐induced injuries by modulating the function of calcium and sodium channels. This property illustrated in the figure could be combined with its antiepileptic activity, which is mediated mainly by the GABA system.</description><subject>alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid - pharmacokinetics</subject><subject>Animals</subject><subject>Brain-Derived Neurotrophic Factor - pharmacology</subject><subject>Calcium - metabolism</subject><subject>Cells, Cultured</subject><subject>Cerebral Cortex - cytology</subject><subject>Dioxolanes - pharmacology</subject><subject>Embryo, Mammalian</subject><subject>Fibrinolytic Agents - pharmacokinetics</subject><subject>Glucose - deficiency</subject><subject>Glutamic Acid - pharmacology</subject><subject>Hippocampus - cytology</subject><subject>Hirudins - pharmacokinetics</subject><subject>L-glutamate</subject><subject>Mice, Inbred C57BL</subject><subject>Neurofilament Proteins - metabolism</subject><subject>Neuroglia - drug effects</subject><subject>neuronal-astroglial culture</subject><subject>Neurons - drug effects</subject><subject>neuroprotection</subject><subject>Neuroprotective Agents - pharmacology</subject><subject>oxygen-glucose deprivation</subject><subject>Protein Binding - drug effects</subject><subject>Rats</subject><subject>Receptors, Glutamate - metabolism</subject><subject>Recombinant Proteins - pharmacokinetics</subject><subject>Sodium - metabolism</subject><subject>stiripentol</subject><subject>Tritium - pharmacokinetics</subject><subject>voltage-gated sodium and calcium channels</subject><issn>0360-4012</issn><issn>1097-4547</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp1kU9v1DAQxS1ERZfCgS-AInGBQ1qP7djxkS60tKqWCoF6tJxkQr3kz2I7W_bb47BtD5U4zYz9myf7PULeAD0GStnJevDHjMuyfEYWQLXKRSHUc7KgXNJcUGCH5GUIa0qp1gV_QQ6ZLAAELxckrnDy48aPEevotpjZubi4y8Y2C9F5t8Ehjl125-JtZrPNGIKrOszcsB27LfbpdkbTEO1PzBtMfDMf1rar3dRndmiyMDZzW9_aYcAuvCIHre0Cvr6vR-TH2efvyy_51dfzi-XHq7wWWpR5baFpFcpKsaYVimvLisoWWnJoJQOhASoUYBUIEFVVgmAcWGsrqgVrFPIj8n6vm_73e8IQTe9CjV1nBxynYECVtACpgSb03RN0PU5-SK9LlNBUAmNloj7sqdonHzy2ZuNdb_3OADVzFCZFYf5Fkdi394pT1WPzSD54n4CTPXDnOtz9X8lcrr49SOb7DRci_nncsP6XkYqrwtyszs1SipvT60_X5oz_BQ3go1A</recordid><startdate>201602</startdate><enddate>201602</enddate><creator>Verleye, Marc</creator><creator>Buttigieg, Dorothée</creator><creator>Steinschneider, Rémy</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope></search><sort><creationdate>201602</creationdate><title>Neuroprotective activity of stiripentol with a possible involvement of voltage-dependent calcium and sodium channels</title><author>Verleye, Marc ; Buttigieg, Dorothée ; Steinschneider, Rémy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4948-ca1df7e6b72df4739a25ba59631f6214911be41a71414bb8142312fab0942d7e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid - pharmacokinetics</topic><topic>Animals</topic><topic>Brain-Derived Neurotrophic Factor - pharmacology</topic><topic>Calcium - metabolism</topic><topic>Cells, Cultured</topic><topic>Cerebral Cortex - cytology</topic><topic>Dioxolanes - pharmacology</topic><topic>Embryo, Mammalian</topic><topic>Fibrinolytic Agents - pharmacokinetics</topic><topic>Glucose - deficiency</topic><topic>Glutamic Acid - pharmacology</topic><topic>Hippocampus - cytology</topic><topic>Hirudins - pharmacokinetics</topic><topic>L-glutamate</topic><topic>Mice, Inbred C57BL</topic><topic>Neurofilament Proteins - metabolism</topic><topic>Neuroglia - drug effects</topic><topic>neuronal-astroglial culture</topic><topic>Neurons - drug effects</topic><topic>neuroprotection</topic><topic>Neuroprotective Agents - pharmacology</topic><topic>oxygen-glucose deprivation</topic><topic>Protein Binding - drug effects</topic><topic>Rats</topic><topic>Receptors, Glutamate - metabolism</topic><topic>Recombinant Proteins - pharmacokinetics</topic><topic>Sodium - metabolism</topic><topic>stiripentol</topic><topic>Tritium - pharmacokinetics</topic><topic>voltage-gated sodium and calcium channels</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Verleye, Marc</creatorcontrib><creatorcontrib>Buttigieg, Dorothée</creatorcontrib><creatorcontrib>Steinschneider, Rémy</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Journal of neuroscience research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Verleye, Marc</au><au>Buttigieg, Dorothée</au><au>Steinschneider, Rémy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neuroprotective activity of stiripentol with a possible involvement of voltage-dependent calcium and sodium channels</atitle><jtitle>Journal of neuroscience research</jtitle><addtitle>Journal of Neuroscience Research</addtitle><date>2016-02</date><risdate>2016</risdate><volume>94</volume><issue>2</issue><spage>179</spage><epage>189</epage><pages>179-189</pages><issn>0360-4012</issn><eissn>1097-4547</eissn><abstract>A growing body of data has shown that recurrent epileptic seizures may be caused by an excessive release of the excitatory neurotransmitter glutamate in the brain. Glutamatergic overstimulation results in massive neuronal influxes of calcium and sodium through N‐methyl‐D‐aspartate (NMDA), α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid, and kainic acid glutamate subtype receptors and also through voltage‐gated calcium and sodium channels. These persistent and abnormal sodium and calcium entry points have deleterious consequences (neurotoxicity) for neuronal function. The therapeutic value of an antiepileptic drug would include not only control of seizure activity but also protection of neuronal tissue. The present study examines the in vitro neuroprotective effects of stiripentol, an antiepileptic compound with γ‐aminobutyric acidergic properties, on neuronal–astroglial cultures from rat cerebral cortex exposed to oxygen–glucose deprivation (OGD) or to glutamate (40 µM for 20 min), two in vitro models of brain injury. In addition, the affinity of stiripentol for the different glutamate receptor subtypes and the interaction with the cell influx of Na+ and of Ca2+ enhanced by veratridine and NMDA, respectively, are assessed. Stiripentol (10–100 µM) included in the culture medium during OGD or with glutamate significantly increased the number of surviving neurons relative to controls. Stiripentol displayed no binding affinity for different subtypes of glutamate receptors (IC50 > 100 µM) but significantly blocked the entry of Na+ and Ca2+ activated by veratridine and NMDA, respectively. These results suggest that Na+ and Ca2+ channels could contribute to the neuroprotective properties of sitiripentol. © 2015 Wiley Periodicals, Inc.
Stiripentol protected neurons and astrocytes against seizure‐induced injuries by modulating the function of calcium and sodium channels. This property illustrated in the figure could be combined with its antiepileptic activity, which is mediated mainly by the GABA system.</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>26511438</pmid><doi>10.1002/jnr.23688</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0360-4012 |
ispartof | Journal of neuroscience research, 2016-02, Vol.94 (2), p.179-189 |
issn | 0360-4012 1097-4547 |
language | eng |
recordid | cdi_proquest_miscellaneous_1780516910 |
source | Wiley |
subjects | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid - pharmacokinetics Animals Brain-Derived Neurotrophic Factor - pharmacology Calcium - metabolism Cells, Cultured Cerebral Cortex - cytology Dioxolanes - pharmacology Embryo, Mammalian Fibrinolytic Agents - pharmacokinetics Glucose - deficiency Glutamic Acid - pharmacology Hippocampus - cytology Hirudins - pharmacokinetics L-glutamate Mice, Inbred C57BL Neurofilament Proteins - metabolism Neuroglia - drug effects neuronal-astroglial culture Neurons - drug effects neuroprotection Neuroprotective Agents - pharmacology oxygen-glucose deprivation Protein Binding - drug effects Rats Receptors, Glutamate - metabolism Recombinant Proteins - pharmacokinetics Sodium - metabolism stiripentol Tritium - pharmacokinetics voltage-gated sodium and calcium channels |
title | Neuroprotective activity of stiripentol with a possible involvement of voltage-dependent calcium and sodium channels |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T05%3A21%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neuroprotective%20activity%20of%20stiripentol%20with%20a%20possible%20involvement%20of%20voltage-dependent%20calcium%20and%20sodium%20channels&rft.jtitle=Journal%20of%20neuroscience%20research&rft.au=Verleye,%20Marc&rft.date=2016-02&rft.volume=94&rft.issue=2&rft.spage=179&rft.epage=189&rft.pages=179-189&rft.issn=0360-4012&rft.eissn=1097-4547&rft_id=info:doi/10.1002/jnr.23688&rft_dat=%3Cproquest_cross%3E3895687641%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4948-ca1df7e6b72df4739a25ba59631f6214911be41a71414bb8142312fab0942d7e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1749061228&rft_id=info:pmid/26511438&rfr_iscdi=true |